Cardiovascular Risk Differs for Stone Formers With ESKD
Among patients with nephrolithiasis or urolithiasis, the cardiovascular event rate was 74.4 per 1000 person-years.
Among patients with nephrolithiasis or urolithiasis, the cardiovascular event rate was 74.4 per 1000 person-years.
Male sex is independently associated with a nearly 2-fold increased risk for in-hospital death, among patients with CKD.
In a community-based dialysis program, nearly 10% of patients successfully converted from 3 to 2 hemodialysis sessions per week.
More than two-thirds of patients experienced a more than 5% weight loss with 12 months of etelcalcetide treatment.
A Japanese study showed that light to moderate alcohol drinkers had a significantly decreased risk for chronic kidney disease compared with those who drank no alcohol.
In a study of Swedish women, gestational diabetes that progressed to type 2 diabetes was significantly associated with increased risks for chronic kidney disease and end-stage kidney disease.
Etelcalcetide use in patients with diabetic nephropathy might protect against development of adynamic bone disease, according to investigators.